Biohaven Ltd (BHVN) Stock Price, Quote, News & History

BHVNNYSE
$13.68
-0.17-1.23%
At close: Aug 24, 5:00 PM EST
$13.95
0.271.97%
After Hours: 9:21 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-511.40M
Investing Cash Flow (TTM)
211.26M
Financing Cash Flow (TTM)
371.73M
Free Cash Flow (TTM)
-511.87M
Capital Expenditure (TTM)
-475.00K
Net Change in Cash (TTM)
71.60M

Analyst Trends and Forecast

2
1
Mar
1
Apr
2
1
May
1
Jun
2
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.12B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
171.16
Earnings Yield % (TTM)
-32.85%
Earnings Yield % (FWD)
-23.10%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.08

Company Debt

Total Debt
$259.48M
LT Debt
$259.48M
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-
Total Cash
$238.03M
Debt to Equity
24.30
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
-

Key Statistics

Open
$13.95
Close
$13.68
Volume / Avg.
1.36M / 2.84M
Day Range
$13.56 - $14.00
52 Wk Range
7.48 - 18.57
Market Cap
$2.11B
P/E Ratio
-
Dividend Yield
-
Exchange
NYSE
RSI
45
Short Interest
15.4%
Days to Cover
9.27

About

Sector
Health Care
Industry
Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline inclu...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Biohaven (BHVN) stock?

A

Biohaven has a consensus price target of $33.50.

Q

What is the current price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $13.95 last updated August 24, 2026 at 9:21 AM EDT.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven does not have any upcoming earnings scheduled.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.